Cargando…

Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy

PURPOSE: To calculate the dose distribution using Monte Carlo simulations for a novel high‐dose‐rate Yttrium‐90 (Y‐90) disc source recently developed for episcleral brachytherapy and provide a lookup table for treatment planning. METHODS: Monte Carlo simulations were performed to calculate the in‐wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xiangyun, Huang, Lyu, Liu, Jian, Cao, Yijian, Chang, Jenghwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691622/
https://www.ncbi.nlm.nih.gov/pubmed/37708092
http://dx.doi.org/10.1002/acm2.14140
_version_ 1785152772559077376
author Chang, Xiangyun
Huang, Lyu
Liu, Jian
Cao, Yijian
Chang, Jenghwa
author_facet Chang, Xiangyun
Huang, Lyu
Liu, Jian
Cao, Yijian
Chang, Jenghwa
author_sort Chang, Xiangyun
collection PubMed
description PURPOSE: To calculate the dose distribution using Monte Carlo simulations for a novel high‐dose‐rate Yttrium‐90 (Y‐90) disc source recently developed for episcleral brachytherapy and provide a lookup table for treatment planning. METHODS: Monte Carlo simulations were performed to calculate the in‐water dose distribution of the Y‐90 disc source using the “GATE”, a software based on the “Geant4” Monte Carlo simulation toolkit developed by the international OpenGATE collaboration. The geometry of this novel beta source, its capsule, and the surrounding water medium were accurately modeled in the simulation input files. The standard Y‐90 element beta spectrum from ICRU 72 was used, and the physics processes for beta and photon interactions with matters were all included. The dose distribution of this Y‐90 disc source was measured in a separate study using Gafchromic EBT‐3 films and the results were reported elsewhere. To match the setup of the experiment, a Gafchromic EBT‐3 film was also included in the simulation geometry. The simulated dose profiles were exported from the 3D dose distribution results and compared with the measured dose profiles. Transverse dose profiles at different distances from the seed surface were also obtained to study the lateral coverage of the source. RESULTS: The measured percent depth dose (PDD) curves along the central axis perpendicular to the surface of the Y‐90 disc were constructed from the experimental and simulated data, and normalized to the reference point at 1 mm from the source capsule. Both PDD curves agreed well up to 4 mm from the source surface (maximum difference ± 10%) but deviated from each other beyond 4 mm. The deviation might be caused by the increased measurement uncertainty in the low‐dose region. The dose rate at the reference point calculated from the Monte Carlo simulation was 1.09 cGy/mCi‐s and agreed very well with the measured dose rate of 1.05 cGy/mCi‐s. If the 80% isodose line is selected as the lateral coverage, the lateral dose coverage is maximal (∼4.5 mm) at the plane next to the source surface, and gradually decreases with the increasing distance, approaching 3.5 mm when the plane is 5 mm from the 6‐mm diameter source surface. CONCLUSION: Monte Carlo simulations were successfully performed to confirm the measured PDD curve of the novel Y‐90 disc source. This simulation work laid a solid foundation for characterizing the full dosimetry parameters of this source for episcleral brachytherapy applications.
format Online
Article
Text
id pubmed-10691622
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106916222023-12-02 Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy Chang, Xiangyun Huang, Lyu Liu, Jian Cao, Yijian Chang, Jenghwa J Appl Clin Med Phys Other Topics PURPOSE: To calculate the dose distribution using Monte Carlo simulations for a novel high‐dose‐rate Yttrium‐90 (Y‐90) disc source recently developed for episcleral brachytherapy and provide a lookup table for treatment planning. METHODS: Monte Carlo simulations were performed to calculate the in‐water dose distribution of the Y‐90 disc source using the “GATE”, a software based on the “Geant4” Monte Carlo simulation toolkit developed by the international OpenGATE collaboration. The geometry of this novel beta source, its capsule, and the surrounding water medium were accurately modeled in the simulation input files. The standard Y‐90 element beta spectrum from ICRU 72 was used, and the physics processes for beta and photon interactions with matters were all included. The dose distribution of this Y‐90 disc source was measured in a separate study using Gafchromic EBT‐3 films and the results were reported elsewhere. To match the setup of the experiment, a Gafchromic EBT‐3 film was also included in the simulation geometry. The simulated dose profiles were exported from the 3D dose distribution results and compared with the measured dose profiles. Transverse dose profiles at different distances from the seed surface were also obtained to study the lateral coverage of the source. RESULTS: The measured percent depth dose (PDD) curves along the central axis perpendicular to the surface of the Y‐90 disc were constructed from the experimental and simulated data, and normalized to the reference point at 1 mm from the source capsule. Both PDD curves agreed well up to 4 mm from the source surface (maximum difference ± 10%) but deviated from each other beyond 4 mm. The deviation might be caused by the increased measurement uncertainty in the low‐dose region. The dose rate at the reference point calculated from the Monte Carlo simulation was 1.09 cGy/mCi‐s and agreed very well with the measured dose rate of 1.05 cGy/mCi‐s. If the 80% isodose line is selected as the lateral coverage, the lateral dose coverage is maximal (∼4.5 mm) at the plane next to the source surface, and gradually decreases with the increasing distance, approaching 3.5 mm when the plane is 5 mm from the 6‐mm diameter source surface. CONCLUSION: Monte Carlo simulations were successfully performed to confirm the measured PDD curve of the novel Y‐90 disc source. This simulation work laid a solid foundation for characterizing the full dosimetry parameters of this source for episcleral brachytherapy applications. John Wiley and Sons Inc. 2023-09-14 /pmc/articles/PMC10691622/ /pubmed/37708092 http://dx.doi.org/10.1002/acm2.14140 Text en © 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Other Topics
Chang, Xiangyun
Huang, Lyu
Liu, Jian
Cao, Yijian
Chang, Jenghwa
Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title_full Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title_fullStr Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title_full_unstemmed Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title_short Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
title_sort monte carlo dosimetry of a novel yttrium‐90 disc source for episcleral brachytherapy
topic Other Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691622/
https://www.ncbi.nlm.nih.gov/pubmed/37708092
http://dx.doi.org/10.1002/acm2.14140
work_keys_str_mv AT changxiangyun montecarlodosimetryofanovelyttrium90discsourceforepiscleralbrachytherapy
AT huanglyu montecarlodosimetryofanovelyttrium90discsourceforepiscleralbrachytherapy
AT liujian montecarlodosimetryofanovelyttrium90discsourceforepiscleralbrachytherapy
AT caoyijian montecarlodosimetryofanovelyttrium90discsourceforepiscleralbrachytherapy
AT changjenghwa montecarlodosimetryofanovelyttrium90discsourceforepiscleralbrachytherapy